Gemzar

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
OBJECTIVE The study aims to evaluate the anti-tumor activity and toxicity of gemcitabine in patients with persistent or recurrent… (More)
Is this relevant?
2011
2011
Gemcitabine (Gemzar(®)) is the first line treatment for pancreatic cancer and often used in combination therapy for non-small… (More)
Is this relevant?
2010
2010
The systemic efficacy of the chemotherapeutic agents presently used to treat solid tumors is limited by their low therapeutic… (More)
Is this relevant?
2010
2010
Pancreatic cancer has a poor prognosis, mainly due to lack of effective therapies. This study demonstrated the ability of dietary… (More)
Is this relevant?
2009
2009
This report demonstrates the formation and characterization of sonochemically prepared bovine serum albumin (BSA)-Gemzar… (More)
Is this relevant?
2007
2007
This paper focuses on the inhibition of ribonucleotide reductase (RNR) by gemcitabine, 2',2'-difluoro-2'-deoxycytidine (dFdC), a… (More)
Is this relevant?
Review
2005
Review
2005
Lentinan is a beta(1-3) glucan clarified to have a life prolonging effect in non-operable, recurrent gastric cancer patients in… (More)
Is this relevant?
2003
2003
We report one new case of hemolytic-uremic syndrome (HUS) and one case of digital necrosis after treatment with gemcitabine… (More)
Is this relevant?
Review
2002
Review
2002
The gemcitabine/cisplatin combination is a key regimen in unresectable locally advanced and metastatic non-small-cell lung cancer… (More)
Is this relevant?
1999
1999
Gemcitabine (Gemzar) has a significant impact upon survival and quality of life for patients with pancreatic cancer, compared… (More)
Is this relevant?